Neurocognitive effects experienced by advanced cancer survivors after immunotherapy

Nathalie Vanlaer

Faculteit van de Geneeskunde en Farmacie
Observerende Klinische wetenschappen

Pers / media: !!Research

Description

Interview with Medimix Oncology at the ESMO Congress 2023 in Madrid.

https://www.linkedin.com/posts/medimixbelgium_medimix-esmo2023-cancersurvivorship-activity-7136340526676500480-ZR7L/?utm_source=share&utm_medium=member_desktop

Periode	1 dec. 2023

Mediabijdrages

Titel	Neurocognitive effects experienced by advanced cancer survivors after immunotherapy
Media naam/outlet	MediMix oncology
Land/Regio	Belgium
Release datum	1/12/23
Beschrijving	https://www.linkedin.com/posts/medimixbelgium_medimix-esmo2023-cancersurvivorship-activity-7136340526676500480-ZR7L/?utm_source=share&utm_medium=member_desktop
URL	https://medimix.be/onco/esmo-2023/?utm_source=LinkedIn&utm_campaign=ESMO_2023
Personen	Nathalie Vanlaer

Alle bekijken 1

Minder bekijken